Sort by
Refine Your Search
-
Country
-
Employer
- ;
- ; The University of Manchester
- ; University of Cambridge
- AcademicTransfer
- CNRS
- Delft University of Technology
- Delft University of Technology (TU Delft)
- ETH Zurich
- Helmholtz
- Institut Lumière Matière ILM- UMR 5306 CNRS / Université Claude Bernard Lyon 1
- Karolinska Institutet
- RMIT University
- Technical University of Denmark
- Trinity College Dublin
- University of Cambridge
- University of Nicosia Medical School
- University of Nottingham
- 7 more »
- « less
-
Field
-
latest developments in antibody phage display technology, coupling the binding of vast antibody-phage libraries containing billions of potential binders with the screening power of next generation
-
26 May 2024 Job Information Organisation/Company CNRS Department Laboratoire de Biologie Intégrative des Modèles Marins Research Field Biological sciences » Botany Biological sciences Technology
-
Institut Lumière Matière ILM- UMR 5306 CNRS / Université Claude Bernard Lyon 1 | Villeurbanne, Rhone Alpes | France | about 2 months ago
25 Apr 2024 Job Information Organisation/Company Institut Lumière Matière ILM- UMR 5306 CNRS / Université Claude Bernard Lyon 1 Research Field Engineering Physics Researcher Profile Recognised
-
, or bioreactor supplemented, cytokine biomarkers. For the first time, we aim to combine this novel switchable technology with complementary metal-oxide-semiconductors (CMOS), enabling on-demand electrochemical
-
24 May 2024 Job Information Organisation/Company Delft University of Technology (TU Delft) Research Field Technology Researcher Profile First Stage Researcher (R1) Country Netherlands Application
-
throughout Europe. Your project: Within our consortium, we set out to evaluate various omics data types such as auto-antibody panels, NMR metabolomics, and RNA sequencing for their potential to enhance
-
throughout Europe. Your project: Within our consortium, we set out to evaluate various omics data types such as auto-antibody panels, NMR metabolomics, and RNA sequencing for their potential to enhance
-
single cell biology technologies as well as antibody engineering, high dimensional flow cytometry and functional assays to understand molecular mechanisms of various autoimmune diseases. The candidate will
-
assembly. The project will be run in collaboration with industrial partners at AstraZeneca, GSK, Merck and Codexis. Together we will focus on developing next generation enzymatic peptide assembly technology
-
single-cells To demonstrate the potential applications of the technology in studying biological processes, such as antibody production in immune cells and its connection with the biophysical and